Suppression of multidrug resistance by rosiglitazone treatment in human ovarian cancer cells through downregulation of FZD1 and MDR1 genes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Suppression of multidrug resistance by rosiglitazone treatment in human ovarian cancer cells through downregulation of FZD1 and MDR1 genes

Published:2015-08 Issue:7 Volume:26 Page:706-715
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Zhang Hui,Jing Xuanxuan,Wu Xiaojuan,Hu Jing,Zhang Xiaofang,Wang Xiao,Su Peng,Li Weiwei,Zhou Gengyin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference42 articles.

1. Cancer statistics, 2010.;Jemal;CA Cancer J Clin,2010

2. . Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.;Ozols;J Clin Oncol,2003

3. Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter.;Gao;Cancer Lett,2007

4. Ovarian cancer: strategies for overcoming resistance to chemotherapy.;Agarwal;Nat Rev Cancer,2003

5. New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives.;Zhang;Future Oncol,2010

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frizzled receptors (FZDs) in Wnt signaling: potential therapeutic targets for human cancers;Acta Pharmacologica Sinica;2024-04-17

2. Diabetes and ovarian cancer: risk factors, molecular mechanisms and impact on prognosis;Endocrine;2023-08-08

3. A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies;International Journal of Molecular Sciences;2023-07-07

4. FZD1/KLF10-hsa-miR-4762-5p/miR-224-3p-circular RNAs axis as prognostic biomarkers and therapeutic targets for glioblastoma: a comprehensive report;BMC Medical Genomics;2023-02-08

5. The medicinal perspective of 2,4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review;Archiv der Pharmazie;2022-06-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3